50 participants
Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-30
- Start Date:
- 2026-03-17
- Completion:
- 2029-03-21
Conditions
- Large B-cell Lymphoma
Interventions
- PROCEDURE
- DRUG
No Results Yet